Did Donald Beyer buy Intellia Therapeutics stock?

Common questions

Did Donald Beyer buy Intellia Therapeutics stock?

Yes. Donald Beyer disclosed 2 purchases and 5 sales of Intellia Therapeutics (NTLA) stock between Jan 14, 2020 and Oct 29, 2021, in STOCK Act reports. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $5K-$75K.

How big were Donald Beyer's Intellia Therapeutics trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $5K-$75K.

Did Donald Beyer make these Intellia Therapeutics trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Donald Beyer still own Intellia Therapeutics stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Donald Beyer report these trades?

The latest filing is dated Oct 30, 2021. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.